| The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland. | |
| | |
MedLine Citation:
|
PMID: 19346023 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: To explore and compare the impact of generic substitution (GS) on the turnover and gross margin per cent of pharmaceutical companies representing mainly original or generic products in Finland. METHODS: A mail survey to pharmaceutical companies with an office in Finland and substitutable medicines in the Finnish pharmaceutical market 1 year (2004) and nearly 5 years (2008) after GS. The questionnaire were answered by 16 original and 7 generic product companies in 2004 (response rate 56%, n=41) and by 16 original and 6 generic product companies in 2008 (response rate 56%, n=39). RESULTS: Turnover had decreased in the original product companies and increased in the generic product companies. The gross margin per cent had decreased in the original and generic product companies, and the companies had also compensated for it in many ways. CONCLUSIONS: The study suggests that GS has promoted the sales of generic product companies in Finland. However, price competition caused by GS has generally decreased the proportion of profit from turnover in the original and generic product companies. The companies have also compensated for their decreased gross margin, which suggests that the profit in euros has not been sufficient to cover fixed costs in the companies. |
| | |
Authors:
|
Johanna Timonen; Pekka Karttunen; Marina Bengtström; Riitta Ahonen |
Related Documents
:
|
16471383 - Embezzlement--don't let it happen to you! 21252883 - The prosthetic management of gingival aesthetics. 8842073 - Doctors' retainer scheme in scotland: time for change? |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-04-05 |
Journal Detail:
|
Title: Health policy (Amsterdam, Netherlands) Volume: 92 ISSN: 0168-8510 ISO Abbreviation: Health Policy Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-08-31 Completed Date: 2010-12-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8409431 Medline TA: Health Policy Country: Ireland |
Other Details:
|
Languages: eng Pagination: 116-23 Citation Subset: H |
Affiliation:
|
Department of Social Pharmacy, University of Kuopio, Finland. Johanna.Timonen@uku.fi |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Commerce
/
statistics & numerical data* Cross-Sectional Studies Drug Industry / economics* Drug Prescriptions Drugs, Generic / economics*, supply & distribution Economic Competition Finland Questionnaires |
| Chemical | |
Reg. No./Substance:
|
0/Drugs, Generic |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Enzymatic inhibition by allyl isothiocyanate and factors affecting its antimicrobial action against ...
Next Document: Overcoming barriers to priority setting using interdisciplinary methods.